Skip to content

eRAPID cognitive interview study

Reviewing the validity of items for patients to self report adverse events: A patient cognitive interview study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN58893387
Enrollment
60
Registered
2011-12-02
Start date
2011-07-18
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, breast cancer, gynaecological cancer, renal cancer, lung cancer Cancer Malignant neoplasms of independent (primary) multiple sites

Interventions

We plan to approach 60 gynaecological, renal, breast, lung and colorectal cancer patients attending St James? University Hospital Bexley Wing as an inpatient outpatient or day case who are receiving b

Sponsors

University of Leeds (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Undergoing chemotherapy and biological treatment with curative or palliative intent 2. Able and willing to give informed consent 3. Have gynaecological, breast, lung, renal and colorectal cancer 4. Male or female 5. Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: 1. If taking part in other studies run by the group 2. If not able to read and understand English 3. If exhibiting overt psychopathology or serious cognitive dysfunction which would impede their being able to take part in the study

Design outcomes

Primary

MeasureTime frame
A bank of adverse event items

Secondary

MeasureTime frame
No secondary outcome measures

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026